Nonalcoholic Steatohepatitis (NASH) Market: Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight

Nonalcoholic Steatohepatitis (NASH) is the progressive form of liver injury that carries a risk of progressive fibrosis, cirrhosis, and end-stage liver disease. It is an advanced form of nonalcoholic fatty liver disease (NAFLD), caused by the buildup of fat in the liver. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver. Scarring of the liver is a potentially life-threatening condition called cirrhosis. NASH usually comes under the category of silent diseases that has very few or no symptoms typically because it does not cause any symptoms until it is too late. In the early period, patients did not complain about anything specific. Even with the advancing fibrosis, the disease may not have any specific problems. However, in the later stages, patients may start developing some non-specific symptoms.

DelveInsight's "Nonalcoholic Steatohepatitis (NASH) Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Nonalcoholic Steatohepatitis (NASH), historical and forecasted epidemiology as well as the Nonalcoholic Steatohepatitis (NASH) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some facts of Nonalcoholic Steatohepatitis (NASH) Market are:

·         Of all the prevalent cases of NAFLD in the 7MM, approximately 19% of the population fulfilled the criteria for NASH. These cases are expected to increase throughout the study period [2018–2030].

·         We estimate the highest prevalence of NASH in the United States, accounting close to 50% of the total prevalent cases, followed by Japan.

·         On the other hand, it is assessed that among the European countries, Germany accounted for the highest prevalent population, followed by Italy. Among all the 7MM countries, Spain had the lowest prevalent population.

·         Namodenoson (CF102) by Can-Fite BioPharma, Belapectin (GR-MD-02) by Galectin Therapeutics, and Immuron’s IMM-124E is expected to enter the NASH therapeutics market.

Request for Sample Report: https://www.delveinsight.com/sample-request/nonalcoholic-steatohepatitis-nash-market

Scope of the Nonalcoholic Steatohepatitis (NASH) Market Report

·         The report covers the descriptive overview of Nonalcoholic Steatohepatitis (NASH), explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies

·         Comprehensive insight has been provided into the Nonalcoholic Steatohepatitis (NASH) epidemiology and treatment in the 7MM

·         Additionally, an all-inclusive account of both the current and emerging therapies for Nonalcoholic Steatohepatitis (NASH) are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape

·         A detailed review of Nonalcoholic Steatohepatitis (NASH) market; historical and forecasted is included in the report, covering drug outreach in the 7MM

·         The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Nonalcoholic Steatohepatitis (NASH) market

The classification of fibrosis stages of NASH is as follows: No Fibrosis (F0), NASH Fibrosis (F1–F3), and NASH Cirrhosis (F4). According to various studies, such as Schuppan et al. (2018), Singh et al. (2014), and others, NASH has been defined to keep progressing from early stages (F0 and F1) to advanced stages (F2–F4) over time. The development of NASH with cirrhosis increases the risk of NASH Decompensated Cirrhosis and ultimately to death.

Request for Sample Report: https://www.delveinsight.com/sample-request/nonalcoholic-steatohepatitis-nash-market

Some of Nonalcoholic Steatohepatitis (NASH) Companies are:

·         Ascletis Pharma

·         Bristol-Myers Squibb (BMS)

·         Can-Fite BioPharma

·         Cirius Therapeutics

·         Enyo Pharma

·         Galectin Therapeutics

·         Galmed Pharmaceuticals Ltd.

·         Genfit

·         Gilead Sciences

·         Immuron

·         Intercept Pharmaceuticals

·         Inventiva Pharma

·         Madrigal Pharmaceuticals

·         MediciNova

·         Mitsubishi Tanabe Pharma

·         NGM Biopharmaceuticals

·         Novo Nordisk

·         Oramed Pharmaceuticals

·         TaiwanJ Pharmaceuticals

·         Terns Pharmaceuticals

·         And Many Others

Request for Sample Report: https://www.delveinsight.com/sample-request/nonalcoholic-steatohepatitis-nash-market

Some of Nonalcoholic Steatohepatitis (NASH) Therapies are:

·         Elafibranor (GFT505)

·         Obeticholic Acid (OCA, Ocaliva)

·         Selonsertib (SEL, Formerly GS-4997)

·         Cilofexor (GS-9674)

·         Firsocostat (GS-0976)

·         Aramchol

·         Pegbelfermin (BMS-986036)

·         IMM-124E

·         Belapectin (GR-MD-02)

·         MSDC-0602K

·         NGM282 (aldafermin)

·         JKB-122

·         Semaglutide

·         LJC242

·         LJN452 (Tropifexor)

·         MT-3995 (Apararenone)

·         MN-001 (Tipelukast)

·         Resmetirom (MGL-3196)

·         Lanifibranor (IVA33)

·         Namodenoson (CF102)

·         ORMD-0801

·         ASC40

·         TERN-101

·         EYP001

·         And Many Others

Table of Contents:

1. Key Insights

2. Executive Summary of Nonalcoholic Steatohepatitis

3. Competitive Intelligence Analysis for Nonalcoholic Steatohepatitis

4. Nonalcoholic Steatohepatitis: Market Overview at a Glance

5. Nonalcoholic Steatohepatitis: Disease Background and Overview

6. Patient Journey

7. Nonalcoholic Steatohepatitis Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Nonalcoholic Steatohepatitis Treatment and Management

8.2. Nonalcoholic Steatohepatitis Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Nonalcoholic Steatohepatitis Treatment

11. Marketed Products

List to be continued in report

12. Emerging Therapies

List to be continued in report

13. Nonalcoholic Steatohepatitis: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Nonalcoholic Steatohepatitis

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

Some of Newly Launched Report: 

·         Defibrillators market

·         Advanced Wound Care market

·         Coronary Stents market

·         Neuromodulation Devices market

·         Neurostimulation Devices market

·         Hernia repair devices market

·         Hyperhidrosis market

About Delveinsight: 

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

Media Contact

 Company Name: DelveInsight Business Research LLP

 Contact Person: Ankit Nigam

 Email: info@delveinsight.com

 Phone: +19193216187

 City: Albany

 State: New York

 Country: United States

 Website: https://www.delveinsight.com/

 

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t...
Read more

Cervical Intraepithelial Neoplasia Market and Epidemiology 2032 by DelveInsight

DelveInsight's " Cervical Intraepithelial Neoplasia Market Insights, Epidemiology, and Market Forecast-2032 " report delivers an in-depth understanding of Cervical Intraepithelial Neoplasia, historical and forecasted epidemiology as well as the Cervical Intraepithelial Neoplasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Cervical Intraepithelial Neoplasia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Cervical Intraepithelial Neoplasia market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Cervical Intraepithelial Neoplasia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Cervical Intraepithelial Neoplasia market. Request for a Free Sample Report: Cervic...
Read more

The Need And The Importance Of The Healthcare Reports for the Pharma Companies

Image
It is very important for the hospitals and the other medical institutions to preserve and keep the healthcare reports of all the patients very safe and secure. All the medical records are being kept by almost all of these institutes. As a matter of fact, the healthcare reports are very important for comprehending the medical history of the patient. If he or she suffers from the same ailment once more the previous reports will be absolutely indispensible while treating him or her. Nowadays, with the advancement of technology the manual records are slowly and gradually getting digitalized. It is easier to store and preserve the digital records than the manual and the physical ones.  Choosing The Best And The Most Professional Services For Healthcare Reports: • Rising Pharma Market for You Now In the market there are a host of companies that preserves the healthcare reports of the various patients. All of it is now being done in the digital format due to the adv...
Read more